AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Debt-to-EBITDA : N/A (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is AfterNext HealthTech Acquisition Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

AfterNext HealthTech Acquisition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $2.00 Mil. AfterNext HealthTech Acquisition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.00 Mil. AfterNext HealthTech Acquisition's annualized EBITDA for the quarter that ended in Jun. 2023 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for AfterNext HealthTech Acquisition's Debt-to-EBITDA or its related term are showing as below:

AFTR' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.82 Med: -1.36 Max: -1.36
Current: -1.82

During the past 2 years, the highest Debt-to-EBITDA Ratio of AfterNext HealthTech Acquisition was -1.36. The lowest was -1.82. And the median was -1.36.

AFTR's Debt-to-EBITDA is not ranked
in the Diversified Financial Services industry.
Industry Median: 3.96 vs AFTR: -1.82

AfterNext HealthTech Acquisition Debt-to-EBITDA Historical Data

The historical data trend for AfterNext HealthTech Acquisition's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AfterNext HealthTech Acquisition Debt-to-EBITDA Chart

AfterNext HealthTech Acquisition Annual Data

Trend

Dec21

Dec22

Debt-to-EBITDA

N/A

-1.36

AfterNext HealthTech Acquisition Quarterly Data
	Apr21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Debt-to-EBITDA	Get a 7-Day Free Trial				N/A	-1.48	-1.36	-1.28	N/A

Competitive Comparison of AfterNext HealthTech Acquisition's Debt-to-EBITDA

For the Shell Companies subindustry, AfterNext HealthTech Acquisition's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AfterNext HealthTech Acquisition's Debt-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, AfterNext HealthTech Acquisition's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AfterNext HealthTech Acquisition's Debt-to-EBITDA falls into.

AfterNext HealthTech Acquisition Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

AfterNext HealthTech Acquisition's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(2	+	0)	/	-1.468
	=	-1.36

AfterNext HealthTech Acquisition's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(2	+	0)	/	0
	=	N/A

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2023) EBITDA data.

AfterNext HealthTech Acquisition (NYSE:AFTR) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

AfterNext HealthTech Acquisition Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AfterNext HealthTech Acquisition's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » AfterNext HealthTech Acquisition Corp (NYSE:AFTR) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

301 Commerce Street, Suite 3300, City Fort Worth, TX, USA, 76102

Website

AfterNext HealthTech Acquisition Corp is a blank check company.

Executives

Jon Winkelried	director, 10 percent owner	C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Tpg Gp A, Llc	director, 10 percent owner	301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
R Halsey Wise	director, officer: Chief Executive Officer	135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Julie L. Gerberding	director	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Bonderman	director, 10 percent owner	301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
James G Coulter	director, 10 percent owner	301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Tpg Group Holdings (sbs) Advisors, Inc.	director, 10 percent owner	C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Jeffrey K. Rhodes	director	C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Christopher H. Hunter	director	500 W MAIN STREET, LOUISVILLE KY 40202
Bharat Sundaram	director	100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Martin Davidson	officer: Chief Financial Officer	C/O TPG PACE ENERGY HOLDINGS CORP., 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Nehal Raj	director	C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Anthony Jr Colaluca	director, officer: President	MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
William Joseph Miller	director	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Agneta G. Breitenstein	director	C/OAFTERNEXT HEALTHTECH ACQUISITION CORP, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102

AfterNext HealthTech Acquisition (AfterNext HealthTech Acquisition) Headlines

From GuruFocus

AfterNext HealthTech Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants Commencing October 4, 2021

By Business Wire Business Wire • 09-29-2021

AfterNext HealthTech Acquisition Corp. Announces Closing of $250 Million Initial Public Offering

By Business Wire Business Wire • 08-16-2021